These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 23524101

  • 1. Different effect of sodium butyrate on cancer and normal prostate cells.
    Paskova L, Smesny Trtkova K, Fialova B, Benedikova A, Langova K, Kolar Z.
    Toxicol In Vitro; 2013 Aug; 27(5):1489-95. PubMed ID: 23524101
    [Abstract] [Full Text] [Related]

  • 2. Formation of AR-SMRT binding in prostate cancer cells treated with natural histone deacetylase inhibitor.
    Trtková K, Pašková L, Matiješčuková N, Kolář Z.
    Cancer Biomark; 2010 Aug; 7(2):79-90. PubMed ID: 21178266
    [Abstract] [Full Text] [Related]

  • 3. Effect of histone deacetylase and DNA methyltransferase inhibitors on the expression of the androgen receptor gene in androgen-independent prostate cancer cell lines.
    Fialova B, Smesny Trtkova K, Paskova L, Langova K, Kolar Z.
    Oncol Rep; 2013 May; 29(5):2039-45. PubMed ID: 23503510
    [Abstract] [Full Text] [Related]

  • 4. Sodium butyrate regulates androgen receptor expression and cell cycle arrest in human prostate cancer cells.
    Kim J, Park H, Im JY, Choi WS, Kim HS.
    Anticancer Res; 2007 May; 27(5A):3285-92. PubMed ID: 17970072
    [Abstract] [Full Text] [Related]

  • 5. Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells.
    Gong J, Zhu J, Goodman OB, Pestell RG, Schlegel PN, Nanus DM, Shen R.
    Oncogene; 2006 Mar 30; 25(14):2011-21. PubMed ID: 16434977
    [Abstract] [Full Text] [Related]

  • 6. Differential effects of PXD101 (belinostat) on androgen-dependent and androgen-independent prostate cancer models.
    Gravina GL, Marampon F, Giusti I, Carosa E, Di Sante S, Ricevuto E, Dolo V, Tombolini V, Jannini EA, Festuccia C.
    Int J Oncol; 2012 Mar 30; 40(3):711-20. PubMed ID: 22134754
    [Abstract] [Full Text] [Related]

  • 7. HOXC8 inhibits androgen receptor signaling in human prostate cancer cells by inhibiting SRC-3 recruitment to direct androgen target genes.
    Axlund SD, Lambert JR, Nordeen SK.
    Mol Cancer Res; 2010 Dec 30; 8(12):1643-55. PubMed ID: 21047772
    [Abstract] [Full Text] [Related]

  • 8. Binding of AR to SMRT/N-CoR complex and its co-operation with PSA promoter in prostate cancer cells treated with natural histone deacetylase inhibitor NaB.
    Trtkova K, Paskova L, Matijescukova N, Strnad M, Kolar Z.
    Neoplasma; 2010 Dec 30; 57(5):406-14. PubMed ID: 20568894
    [Abstract] [Full Text] [Related]

  • 9. Differently regulated androgen receptor transcriptional complex in prostate cancer compared with normal prostate.
    Kinoshita M, Nakagawa T, Shimizu A, Katsuoka Y.
    Int J Urol; 2005 Apr 30; 12(4):390-7. PubMed ID: 15948728
    [Abstract] [Full Text] [Related]

  • 10. Epigenetic modulation of AR gene expression in prostate cancer DU145 cells with the combination of sodium butyrate and 5'-Aza-2'-deoxycytidine.
    Fialova B, Luzna P, Gursky J, Langova K, Kolar Z, Trtkova KS.
    Oncol Rep; 2016 Oct 30; 36(4):2365-74. PubMed ID: 27499010
    [Abstract] [Full Text] [Related]

  • 11. Recruitment of HDAC4 by transcription factor YY1 represses HOXB13 to affect cell growth in AR-negative prostate cancers.
    Ren G, Zhang G, Dong Z, Liu Z, Li L, Feng Y, Su D, Zhang Y, Huang B, Lu J.
    Int J Biochem Cell Biol; 2009 May 30; 41(5):1094-101. PubMed ID: 19013255
    [Abstract] [Full Text] [Related]

  • 12. Regulation of T-type calcium channel expression by sodium butyrate in prostate cancer cells.
    Weaver EM, Zamora FJ, Puplampu-Dove YA, Kiessu E, Hearne JL, Martin-Caraballo M.
    Eur J Pharmacol; 2015 Feb 15; 749():20-31. PubMed ID: 25557765
    [Abstract] [Full Text] [Related]

  • 13. Potentiation of androgen receptor transcriptional activity by inhibition of histone deacetylation--rescue of transcriptionally compromised mutants.
    Korkmaz CG, Frønsdal K, Zhang Y, Lorenzo PI, Saatcioglu F.
    J Endocrinol; 2004 Sep 15; 182(3):377-89. PubMed ID: 15350180
    [Abstract] [Full Text] [Related]

  • 14. Hypoacetylation, hypomethylation, and dephosphorylation of H2B histones and excessive histone deacetylase activity in DU-145 prostate cancer cells.
    Cang S, Xu X, Ma Y, Liu D, Chiao JW.
    J Hematol Oncol; 2016 Jan 12; 9():3. PubMed ID: 26759222
    [Abstract] [Full Text] [Related]

  • 15. Expressional changes after histone deacetylase inhibition by valproic acid in LNCaP human prostate cancer cells.
    Thelen P, Schweyer S, Hemmerlein B, Wuttke W, Seseke F, Ringert RH.
    Int J Oncol; 2004 Jan 12; 24(1):25-31. PubMed ID: 14654937
    [Abstract] [Full Text] [Related]

  • 16. Valproic acid induces neuroendocrine differentiation and UGT2B7 up-regulation in human prostate carcinoma cell line.
    Valentini A, Biancolella M, Amati F, Gravina P, Miano R, Chillemi G, Farcomeni A, Bueno S, Vespasiani G, Desideri A, Federici G, Novelli G, Bernardini S.
    Drug Metab Dispos; 2007 Jun 12; 35(6):968-72. PubMed ID: 17371798
    [Abstract] [Full Text] [Related]

  • 17. Androgen receptor activity at the prostate specific antigen locus: steroidal and non-steroidal mechanisms.
    Jia L, Kim J, Shen H, Clark PE, Tilley WD, Coetzee GA.
    Mol Cancer Res; 2003 Mar 12; 1(5):385-92. PubMed ID: 12651911
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of MAPK-signaling pathway promotes the interaction of the corepressor SMRT with the human androgen receptor and mediates repression of prostate cancer cell growth in the presence of antiandrogens.
    Eisold M, Asim M, Eskelinen H, Linke T, Baniahmad A.
    J Mol Endocrinol; 2009 May 12; 42(5):429-35. PubMed ID: 19223455
    [Abstract] [Full Text] [Related]

  • 19. DNA demethylation and histone deacetylation inhibition co-operate to re-express estrogen receptor beta and induce apoptosis in prostate cancer cell-lines.
    Walton TJ, Li G, Seth R, McArdle SE, Bishop MC, Rees RC.
    Prostate; 2008 Feb 01; 68(2):210-22. PubMed ID: 18092350
    [Abstract] [Full Text] [Related]

  • 20. Procyanidin B3, an inhibitor of histone acetyltransferase, enhances the action of antagonist for prostate cancer cells via inhibition of p300-dependent acetylation of androgen receptor.
    Choi KC, Park S, Lim BJ, Seong AR, Lee YH, Shiota M, Yokomizo A, Naito S, Na Y, Yoon HG.
    Biochem J; 2011 Jan 01; 433(1):235-44. PubMed ID: 20955177
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.